Get the Stockscreener App
0.535
15.05%
0.07
After Hours:
.54
0.005
+0.93%
Rallybio Corp Stock (RLYB) Forecast
The Rallybio Corp (RLYB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.44, representing a +356.07% increase from the current price of $0.535. The highest analyst price target is $4.33, and the lowest is $0.55.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RLYB Price Target
Average 2.2268
(+316.22% Upside)
Is Rallybio Corp (RLYB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 63.11 | Neutral |
| STOCH(9,6) | 61.28 | Neutral |
| STOCHRSI(14) | 69.95 | Neutral |
| MACD(12,26) | 0.0354 | Buy |
| ADX(14) | 49.18 | Buy |
| William %R | -12.93 | Sell |
| CCI(14) | 48.49 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4956
Buy
|
0.4858
Buy
|
| MA20 |
0.4604
Buy
|
0.4585
Buy
|
| MA50 |
0.3865
Buy
|
0.4212
Buy
|
| MA100 |
0.4074
Buy
|
0.4727
Buy
|
| MA200 |
0.6758
Sell
|
0.6735
Sell
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, RLYB could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on RLYB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 63.11 indicates that RLYB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.28 indicates that RLYB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.95 indicates that RLYB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 49.18 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 48.49 indicates that RLYB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RLYB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rallybio Corp financial reports and earnings history, Rallybio Corp (RLYB) stock could reach $3.7904 by 2030, $50.66 by 2040 and $71.03 by 2050. See the projected annual prices until 2050 of the Rallybio Corp stock below:
- Rallybio Corp (RLYB) is expected to reach an average price of $17.54 in 2035, with a high prediction of $18.03 and a low estimate of $15.30. This indicates an $3,178% rise from the last recorded price of $0.535.
- Rallybio Corp (RLYB) stock is projected to chart a bullish course in 2040, with an average price target of $50.26, representing an $9,295% surge from its current level. The forecast ranges from a conservative $50.95 to a sky-high $50.66.
- Our analysts predict Rallybio Corp (RLYB) to jump 5,459% by 2045, soaring from $29.93 to an average price of $29.74, potentially reaching $31.35. While $29.93 is the low estimate, the potential upside is significant.
- Rallybio Corp (RLYB) stock is expected to climb by 2050, reaching an average of $70.18, a $13,018% jump from its current level. However, a wide range of estimates exists, with high and low targets of $71.03 and $70.96, respectively, highlighting the market's uncertainty.
Rallybio Corp Stock (RLYB) Year by Year Forecast
Rallybio Corp Stock (RLYB) Price Forecast for 2025
Rallybio Corp Stock (RLYB) is expected to reach an average price of $4.4395 in 2025, with a high prediction of $8.8148 and a low estimate of $0.0642. This indicates an +729.82% rise from the last recorded price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $2.8225 | $0.55 | $4.33 | +427.58% |
| October, 2025 | $0.696 | $1.116 | $3.4451 | +30.10% |
| November, 2025 | $0.4809 | $0.9309 | $1.3728 | -10.11% |
| December, 2025 | $1.0905 | $0.0642 | $2.3005 | +103.84% |
Rallybio Corp Stock (RLYB) Price Forecast for 2026
The predicted value for Rallybio Corp (RLYB) in 2026 is set at an average of $2.2268. Estimates vary from a peak of $4.4288 to a trough of $0.0248, indicating an +316.22% surge from the present price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3257 | $0.4432 | $1.5168 | +147.79% |
| February, 2026 | $0.2292 | $0.3992 | $4.3758 | -57.16% |
| March, 2026 | $0.3641 | $0.5741 | $0.7838 | -31.95% |
| April, 2026 | $0.2174 | $0.0248 | $1.0674 | -59.37% |
| May, 2026 | $3.2325 | $0.2337 | $3.3425 | +504.21% |
| June, 2026 | $1.1176 | $0.9226 | $4.4288 | +108.91% |
| July, 2026 | $1.7191 | $0.5702 | $2.0065 | +221.32% |
| August, 2026 | $1.4342 | $0.8866 | $2.2379 | +168.08% |
| September, 2026 | $1.1056 | $0.8906 | $2.1494 | +106.66% |
| October, 2026 | $0.1492 | $0.1992 | $1.3019 | -72.11% |
| November, 2026 | $0.4341 | $0.1229 | $1.1834 | -18.86% |
| December, 2026 | $0.1327 | $1.0327 | $0.7889 | -75.21% |
Rallybio Corp Stock (RLYB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rallybio Corp (RLYB) is $4.3369, with a high forecast of $8.6257 and a low forecast of $0.0481. This indicates an +710.64% increase from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6775 | $0.3164 | $0.3736 | +26.64% |
| February, 2027 | $1.2224 | $0.8912 | $1.1356 | +128.48% |
| March, 2027 | $0.0341 | $0.5608 | $1.1161 | -93.63% |
| April, 2027 | $0.4658 | $0.0553 | $0.4016 | -12.93% |
| May, 2027 | $0.0807 | $0.1907 | $1.5631 | -84.92% |
| June, 2027 | $8.4674 | $0.0481 | $7.7574 | +1,483% |
| July, 2027 | $8.2271 | $8.467 | $7.9535 | +1,438% |
| August, 2027 | $2.9569 | $3.2769 | $6.6146 | +452.69% |
| September, 2027 | $5.004 | $2.9666 | $3.0617 | +835.33% |
| October, 2027 | $7.6737 | $7.0714 | $6.0163 | +1,334% |
| November, 2027 | $9.5635 | $8.7312 | $7.6635 | +1,688% |
| December, 2027 | $6.3806 | $6.5706 | $8.6257 | +1,093% |
Rallybio Corp Stock (RLYB) Price Forecast for 2028
In 2028, Rallybio Corp (RLYB) is projected to reach an average price of $5.6663, with a high projection of $10.07 and a low estimate of $1.2578. This indicates an +959.13% rise from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.5103 | $5.2655 | $4.5903 | +1,117% |
| February, 2028 | $9.36 | $7.1678 | $7.3826 | +1,650% |
| March, 2028 | $8.0472 | $9.3172 | $10.07 | +1,404% |
| April, 2028 | $5.6569 | $7.3569 | $5.762 | +957.37% |
| May, 2028 | $8.9341 | $3.7342 | $6.7141 | +1,570% |
| June, 2028 | $8.0738 | $8.4038 | $8.5015 | +1,409% |
| July, 2028 | $5.8335 | $6.3035 | $6.4512 | +990.37% |
| August, 2028 | $3.5506 | $3.0658 | $3.6409 | +563.67% |
| September, 2028 | $0.5504 | $2.0804 | $2.8481 | +2.87% |
| October, 2028 | $5.8201 | $1.2578 | $4.3301 | +987.87% |
| November, 2028 | $7.5172 | $4.1949 | $6.886 | +1,305% |
| December, 2028 | $7.7569 | $7.3895 | $6.8969 | +1,350% |
Rallybio Corp Stock (RLYB) Price Forecast for 2029
The 2029 price forecast for Rallybio Corp Stock (RLYB) is $3.9696 on average, with a high prediction of $6.1768 and a low estimate of $1.7624. This represents an +641.98% increase from the previous price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.9541 | $6.6741 | $6.1768 | +1,013% |
| February, 2029 | $5.2238 | $5.089 | $4.9515 | +876.41% |
| March, 2029 | $3.3535 | $3.6385 | $4.2638 | +526.83% |
| April, 2029 | $6.2233 | $3.521 | $5.6933 | +1,063% |
| May, 2029 | $4.8204 | $5.6704 | $5.543 | +801.01% |
| June, 2029 | $3.4101 | $3.8901 | $4.3078 | +537.41% |
| July, 2029 | $1.7498 | $1.7624 | $2.3358 | +227.07% |
| August, 2029 | $2.587 | $2.1473 | $2.9221 | +383.55% |
| September, 2029 | $2.4967 | $2.5819 | $2.4419 | +366.67% |
| October, 2029 | $2.4139 | $2.639 | $2.3116 | +351.19% |
| November, 2029 | $3.6836 | $2.8213 | $3.2436 | +588.52% |
| December, 2029 | $2.6333 | $3.1483 | $3.201 | +392.20% |
Rallybio Corp Stock (RLYB) Price Forecast for 2030
Rallybio Corp Stock (RLYB) is expected to reach an average price of $10.05 in 2030, with a high forecast of $18.63 and a low forecast of $1.4636. This signifies an +1,778% surge from the last price of $0.535.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.3604 | $2.9207 | $3.7904 | +715.04% |
| February, 2030 | $3.1802 | $3.2702 | $3.8679 | +494.42% |
| March, 2030 | $3.9299 | $3.3876 | $3.4499 | +634.56% |
| April, 2030 | $3.1496 | $3.6946 | $3.7079 | +488.71% |
| May, 2030 | $2.4868 | $2.1793 | $2.737 | +364.81% |
| June, 2030 | $2.2765 | $2.3465 | $2.4316 | +325.51% |
| July, 2030 | $1.5762 | $1.4636 | $1.6888 | +194.61% |
| August, 2030 | $17.76 | $19.09 | $18.63 | +3,220% |
| September, 2030 | $13.66 | $18.19 | $17.66 | +2,453% |
| October, 2030 | $12.57 | $13.56 | $13.23 | +2,250% |
| November, 2030 | $16.52 | $13.02 | $15.02 | +2,988% |
| December, 2030 | $18.70 | $17.45 | $17.14 | +3,396% |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):